| |
| |
|
| Insider
Information: |
Kranzler Jay D |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
134,308 |
|
|
Indirect Shares
|
96,742 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
231,050 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cypress Bioscience Inc |
CYPB |
CEO, Director |
2010-12-28 |
625 |
2010-12-28 |
96,742 |
Premium* |
|
|
Avenue Therapeutics, Inc. |
ATXI |
Director |
2021-12-17 |
133,683 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ATXI |
Avenue Therapeutics, Inc. |
Director |
– • – |
2021-12-17 |
4 |
A |
$0.00 |
$0 |
D/D |
69,020 |
133,683 |
0 |
- |
|
| ATXI |
Avenue Therapeutics, Inc. |
Director |
– • – |
2020-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
84,663 |
0 |
- |
|
| ATXI |
Avenue Therapeutics, Inc. |
Director |
– • – |
2019-08-27 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
74,663 |
0 |
- |
|
| ATXI |
Avenue Therapeutics, Inc. |
Director |
– • – |
2018-08-07 |
4 |
GA |
$0.00 |
$0 |
D/D |
14,663 |
64,663 |
0 |
- |
|
| ATXI |
Avenue Therapeutics, Inc. |
Director |
– • – |
2017-03-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
50,000 |
|
- |
|
| CYPB |
Cypress Bioscience Inc |
CEO |
• • – |
2010-12-28 |
4 |
S |
$6.46 |
$161,500 |
I/I |
(25,000) |
96,742 |
0 |
- |
|
| CYPB |
Cypress Bioscience Inc |
CEO |
• • – |
2010-12-28 |
4 |
OE |
$3.25 |
$81,250 |
I/I |
25,000 |
121,742 |
0 |
- |
|
| CYPB |
Cypress Bioscience Inc |
CEO |
• • – |
2010-12-23 |
4 |
OE |
$3.25 |
$495,508 |
I/I |
152,464 |
249,206 |
0 |
- |
|
| CYPB |
Cypress Bioscience Inc |
CEO |
• • – |
2010-12-23 |
4 |
S |
$6.45 |
$983,393 |
I/I |
(152,464) |
96,742 |
0 |
- |
|
| CYPB |
Cypress Bioscience Inc |
Chief Executive Officer |
• • – |
2010-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
100,625 |
0 |
- |
|
| CYPB |
Cypress Bioscience Inc |
CEO |
• • – |
2009-08-03 |
4 |
AS |
$8.69 |
$651,848 |
I/I |
(75,000) |
96,742 |
0 |
- |
|
| CYPB |
Cypress Bioscience Inc |
CEO |
• • – |
2009-08-03 |
4 |
OE |
$2.51 |
$188,250 |
I/I |
75,000 |
171,742 |
0 |
- |
|
| CYPB |
Cypress Bioscience Inc |
CEO |
• • – |
2009-07-06 |
4 |
AS |
$8.70 |
$652,613 |
I/I |
(75,000) |
96,742 |
0 |
- |
|
| CYPB |
Cypress Bioscience Inc |
CEO |
• • – |
2009-07-06 |
4 |
OE |
$2.51 |
$188,250 |
I/I |
75,000 |
171,742 |
0 |
- |
|
| CYPB |
Cypress Bioscience Inc |
CEO |
• • – |
2009-03-02 |
4 |
OE |
$2.51 |
$188,250 |
I/I |
75,000 |
171,742 |
0 |
- |
|
| CYPB |
Cypress Bioscience Inc |
CEO |
• • – |
2009-03-02 |
4 |
AS |
$8.19 |
$614,250 |
I/I |
(75,000) |
96,742 |
0 |
- |
|
| CYPB |
Cypress Bioscience Inc |
CEO |
• • – |
2009-02-02 |
4 |
AS |
$8.50 |
$644,908 |
I/I |
(75,000) |
96,742 |
0 |
- |
|
| CYPB |
Cypress Bioscience Inc |
CEO |
• • – |
2009-02-02 |
4 |
OE |
$2.51 |
$188,250 |
I/I |
75,000 |
171,742 |
0 |
- |
|
| CYPB |
Cypress Bioscience Inc |
CEO |
• • – |
2008-01-09 |
4 |
OE |
$2.51 |
$339,572 |
I/I |
96,742 |
96,742 |
0 |
- |
|
| CYPB |
Cypress Bioscience Inc |
CEO |
• • – |
2007-12-24 |
4 |
AS |
$11.51 |
$166,824 |
I/I |
(14,324) |
4,000 |
0 |
- |
|
| CYPB |
Cypress Bioscience Inc |
CEO |
• • – |
2007-12-19 |
4 |
GD |
$0.00 |
$0 |
I/I |
4,000 |
0 |
0 |
- |
|
| CYPB |
Cypress Bioscience Inc |
CEO |
• • – |
2007-11-26 |
4 |
AS |
$11.55 |
$3,465 |
I/I |
(300) |
18,324 |
0 |
- |
|
| CYPB |
Cypress Bioscience Inc |
CEO |
• • – |
2007-11-26 |
4 |
AS |
$11.23 |
$281,689 |
I/I |
(24,700) |
18,624 |
0 |
- |
|
| CYPB |
Cypress Bioscience Inc |
CEO |
• • – |
2007-10-22 |
4 |
AS |
$13.30 |
$323,891 |
I/I |
(24,000) |
44,324 |
0 |
- |
|
| CYPB |
Cypress Bioscience Inc |
CEO |
• • – |
2007-10-22 |
4 |
AS |
$13.62 |
$13,650 |
I/I |
(1,000) |
43,324 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
